Matthew L Sherman
CIK 1325710 · EVP & Chief Medical Officer · last filed 2024-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$28.0K
Companies
5
Total Filings
77
Lifetime Open-Market Net
-$7.83M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | EVP & Chief Medical Officer | 0 | $25.59 | $0 | -$445.2K | 21 | 2024-06-11 |
| PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Director | — | $13.60 | — | $0 | 7 | 2023-06-23 |
| LUMOS PHARMA, INC. (NLNK) Delisted | Director | — | — | — | $0 | 3 | 2019-08-02 |
| PULM | Director | 20,000 | $1.40 | $28.0K | $0 | 5 | 2019-05-20 |
| ACCELERON PHARMA INC (XLRN) Delisted | EVP & Chief Medical Officer | 77,267 | $178.75 | $13.81M | -$7.39M | 41 | 2018-04-04 |
Recent Filings · Page 5 of 8
77 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-01-06 | ACCELERON PHARMA INC (XLRN) Delisted | Sell (S) | −2,000 | -$54.9K | EDGAR |
| 2016-10-03 | PULM | Grant (A) | — | $0 | EDGAR |
| 2016-08-11 | ACCELERON PHARMA INC (XLRN) Delisted | Exer (M) | +18,896 | $131.1K | EDGAR |
| 2016-07-07 | ACCELERON PHARMA INC (XLRN) Delisted | Exer (M) | +6,000 | $31.7K | EDGAR |
| 2016-07-06 | ACCELERON PHARMA INC (XLRN) Delisted | Mixed | −12,000 | -$835.3K | EDGAR |
| 2016-04-08 | ACCELERON PHARMA INC (XLRN) Delisted | Mixed | −12,000 | -$760.9K | EDGAR |
| 2016-03-07 | ACCELERON PHARMA INC (XLRN) Delisted | Grant (A) | +6,000 | $0 | EDGAR |
| 2015-10-16 | ACCELERON PHARMA INC (XLRN) Delisted | Sell (S) | −6,000 | -$139.7K | EDGAR |
| 2015-09-18 | ACCELERON PHARMA INC (XLRN) Delisted | Sell (S) | −2,000 | -$66.5K | EDGAR |
| 2015-09-11 | ACCELERON PHARMA INC (XLRN) Delisted | Grant (A) | +46,000 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.